Cross-specialty identification of the JAK1 inhibitor trial agent filgotinib as a potential therapy for alopecia areata

Br J Dermatol. 2023 Feb 22;188(3):442-443. doi: 10.1093/bjd/ljac103.
No abstract available

MeSH terms

  • Alopecia Areata*
  • Humans
  • Janus Kinase 1
  • Janus Kinase Inhibitors*
  • Pyridines

Substances

  • GLPG0634
  • Janus Kinase Inhibitors
  • Pyridines
  • JAK1 protein, human
  • Janus Kinase 1

Supplementary concepts

  • Diffuse alopecia